Somatic Evolution in Non-neoplastic IBD-Affected Colon

Sigurgeir Ólafsson(Wellcome Sanger Institute), Rebecca E. McIntyre(Wellcome Sanger Institute), Tim Coorens(Wellcome Sanger Institute), Timothy Butler(Wellcome Sanger Institute), Hyunchul Jung(Wellcome Sanger Institute), Philip S. Robinson(University of Cambridge), Henry Lee-Six(Wellcome Sanger Institute), Mathijs A. Sanders(Erasmus MC), Kenneth Arestang(Cambridge University Hospitals NHS Foundation Trust), Claire Dawson(Cambridge University Hospitals NHS Foundation Trust), Monika Tripathi(Cambridge University Hospitals NHS Foundation Trust), Konstantina Strongili(Cambridge University Hospitals NHS Foundation Trust), Yvette Hooks(Wellcome Sanger Institute), Michael R. Stratton(Wellcome Sanger Institute), Miles Parkes(Cambridge University Hospitals NHS Foundation Trust), Iñigo Martincorena(Wellcome Sanger Institute), Tim Raine(Cambridge University Hospitals NHS Foundation Trust), Peter J. Campbell(Wellcome Sanger Institute), Carl A. Anderson(Wellcome Sanger Institute)
Cited by 206Open Access
Full Text

Abstract

Inflammatory bowel disease (IBD) is a chronic inflammatory disease associated with increased risk of gastrointestinal cancers. We whole-genome sequenced 446 colonic crypts from 46 IBD patients and compared these to 412 crypts from 41 non-IBD controls from our previous publication on the mutation landscape of the normal colon. The average mutation rate of affected colonic epithelial cells is 2.4-fold that of healthy colon, and this increase is mostly driven by acceleration of mutational processes ubiquitously observed in normal colon. In contrast to the normal colon, where clonal expansions outside the confines of the crypt are rare, we observed widespread millimeter-scale clonal expansions. We discovered non-synonymous mutations in ARID1A, FBXW7, PIGR, ZC3H12A, and genes in the interleukin 17 and Toll-like receptor pathways, under positive selection in IBD. These results suggest distinct selection mechanisms in the colitis-affected colon and that somatic mutations potentially play a causal role in IBD pathogenesis.


Related Papers

No related papers found

Powered by citation graph analysis